A transgenic mouse was generated as an animal model of Huntington’s disease (HD) in which Drd1a+ cells were slowly but progressively ablated in the postnatal striatum, yet Drd2 single-positive cells were preserved [39]. The gene discussed is DRD1; the disease is Huntington disease.